Antioxidant treatment for impaired hypoxic ventilatory responses in experimental diabetes in the rat
In conclusion, mangiferin holds a therapeutic promise in breaking the mesh of chronic tissue hypoxia, inflammation, and oxidative stress in diabetes by enhancing ventilation.
Source: Respiratory Physiology and Neurobiology - Category: Respiratory Medicine Source Type: research
More News: Antidoxidants | Brain | Diabetes | Endocrinology | Neurology | Physiology | Respiratory Medicine | Study